nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—SLC22A11—Furosemide—dilated cardiomyopathy	0.218	0.304	CbGbCtD
Zidovudine—SLC22A8—Furosemide—dilated cardiomyopathy	0.127	0.177	CbGbCtD
Zidovudine—SLC22A6—Furosemide—dilated cardiomyopathy	0.0884	0.123	CbGbCtD
Zidovudine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0852	0.119	CbGbCtD
Zidovudine—ALB—Furosemide—dilated cardiomyopathy	0.0753	0.105	CbGbCtD
Zidovudine—ABCB1—Lisinopril—dilated cardiomyopathy	0.0655	0.0913	CbGbCtD
Zidovudine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0577	0.0804	CbGbCtD
Zidovudine—CYP2C9—cardial valve—dilated cardiomyopathy	0.0116	0.304	CbGeAlD
Zidovudine—Breath sounds abnormal—Lisinopril—dilated cardiomyopathy	0.00697	0.0426	CcSEcCtD
Zidovudine—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00428	0.0261	CcSEcCtD
Zidovudine—SLC29A2—cardiac ventricle—dilated cardiomyopathy	0.00403	0.106	CbGeAlD
Zidovudine—SLC29A2—myocardium—dilated cardiomyopathy	0.00379	0.0996	CbGeAlD
Zidovudine—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00336	0.0205	CcSEcCtD
Zidovudine—Local reaction—Furosemide—dilated cardiomyopathy	0.00322	0.0197	CcSEcCtD
Zidovudine—TK1—heart—dilated cardiomyopathy	0.0032	0.084	CbGeAlD
Zidovudine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00293	0.0179	CcSEcCtD
Zidovudine—SLC29A2—heart—dilated cardiomyopathy	0.00265	0.0695	CbGeAlD
Zidovudine—SLC29A2—cardiac atrium—dilated cardiomyopathy	0.00226	0.0595	CbGeAlD
Zidovudine—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.00225	0.0137	CcSEcCtD
Zidovudine—ABCC5—cardiac ventricle—dilated cardiomyopathy	0.00218	0.0572	CbGeAlD
Zidovudine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00214	0.0131	CcSEcCtD
Zidovudine—ABCC5—myocardium—dilated cardiomyopathy	0.00205	0.0538	CbGeAlD
Zidovudine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00198	0.0121	CcSEcCtD
Zidovudine—Drug interaction—Furosemide—dilated cardiomyopathy	0.00192	0.0117	CcSEcCtD
Zidovudine—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00187	0.0114	CcSEcCtD
Zidovudine—Vasculitis—Furosemide—dilated cardiomyopathy	0.00183	0.0112	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00182	0.0111	CcSEcCtD
Zidovudine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00171	0.0104	CcSEcCtD
Zidovudine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00167	0.0102	CcSEcCtD
Zidovudine—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00165	0.0101	CcSEcCtD
Zidovudine—Bladder pain—Furosemide—dilated cardiomyopathy	0.00161	0.00984	CcSEcCtD
Zidovudine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00161	0.00984	CcSEcCtD
Zidovudine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00155	0.0095	CcSEcCtD
Zidovudine—Polyuria—Furosemide—dilated cardiomyopathy	0.00147	0.009	CcSEcCtD
Zidovudine—Deafness—Furosemide—dilated cardiomyopathy	0.00145	0.00883	CcSEcCtD
Zidovudine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00144	0.0088	CcSEcCtD
Zidovudine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00143	0.00875	CcSEcCtD
Zidovudine—ABCC5—heart—dilated cardiomyopathy	0.00143	0.0375	CbGeAlD
Zidovudine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00138	0.00841	CcSEcCtD
Zidovudine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00137	0.00837	CcSEcCtD
Zidovudine—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00135	0.00827	CcSEcCtD
Zidovudine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00133	0.00811	CcSEcCtD
Zidovudine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00131	0.00798	CcSEcCtD
Zidovudine—Wheezing—Lisinopril—dilated cardiomyopathy	0.0013	0.00793	CcSEcCtD
Zidovudine—Malaise—Spironolactone—dilated cardiomyopathy	0.00129	0.00789	CcSEcCtD
Zidovudine—Cystitis—Lisinopril—dilated cardiomyopathy	0.00129	0.00789	CcSEcCtD
Zidovudine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00128	0.00783	CcSEcCtD
Zidovudine—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00127	0.00775	CcSEcCtD
Zidovudine—Photophobia—Lisinopril—dilated cardiomyopathy	0.00126	0.00767	CcSEcCtD
Zidovudine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00126	0.00767	CcSEcCtD
Zidovudine—Irritability—Furosemide—dilated cardiomyopathy	0.00123	0.00754	CcSEcCtD
Zidovudine—ABCC5—cardiac atrium—dilated cardiomyopathy	0.00122	0.0321	CbGeAlD
Zidovudine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00121	0.00738	CcSEcCtD
Zidovudine—Discomfort—Spironolactone—dilated cardiomyopathy	0.0012	0.00736	CcSEcCtD
Zidovudine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00118	0.0072	CcSEcCtD
Zidovudine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00117	0.00714	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00116	0.00711	CcSEcCtD
Zidovudine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00114	0.00699	CcSEcCtD
Zidovudine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.0011	0.00669	CcSEcCtD
Zidovudine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00107	0.00657	CcSEcCtD
Zidovudine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00104	0.00635	CcSEcCtD
Zidovudine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00103	0.00631	CcSEcCtD
Zidovudine—ALB—heart—dilated cardiomyopathy	0.00102	0.0269	CbGeAlD
Zidovudine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00101	0.00616	CcSEcCtD
Zidovudine—ABCC4—heart—dilated cardiomyopathy	0.000991	0.026	CbGeAlD
Zidovudine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000988	0.00604	CcSEcCtD
Zidovudine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000963	0.00588	CcSEcCtD
Zidovudine—Sweating—Furosemide—dilated cardiomyopathy	0.000955	0.00584	CcSEcCtD
Zidovudine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000943	0.00576	CcSEcCtD
Zidovudine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00093	0.00568	CcSEcCtD
Zidovudine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000928	0.00567	CcSEcCtD
Zidovudine—Irritability—Lisinopril—dilated cardiomyopathy	0.000926	0.00566	CcSEcCtD
Zidovudine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000924	0.00564	CcSEcCtD
Zidovudine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000884	0.0054	CcSEcCtD
Zidovudine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000877	0.00536	CcSEcCtD
Zidovudine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000877	0.00536	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000874	0.00534	CcSEcCtD
Zidovudine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000868	0.0053	CcSEcCtD
Zidovudine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000846	0.00517	CcSEcCtD
Zidovudine—Influenza—Lisinopril—dilated cardiomyopathy	0.000839	0.00512	CcSEcCtD
Zidovudine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000827	0.00505	CcSEcCtD
Zidovudine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000822	0.00502	CcSEcCtD
Zidovudine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000817	0.00499	CcSEcCtD
Zidovudine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000799	0.00488	CcSEcCtD
Zidovudine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000796	0.00487	CcSEcCtD
Zidovudine—Dysuria—Lisinopril—dilated cardiomyopathy	0.000784	0.00479	CcSEcCtD
Zidovudine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000784	0.00479	CcSEcCtD
Zidovudine—Malnutrition—Furosemide—dilated cardiomyopathy	0.000779	0.00476	CcSEcCtD
Zidovudine—Erythema—Furosemide—dilated cardiomyopathy	0.000779	0.00476	CcSEcCtD
Zidovudine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000773	0.00472	CcSEcCtD
Zidovudine—Flatulence—Furosemide—dilated cardiomyopathy	0.000767	0.00469	CcSEcCtD
Zidovudine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000763	0.00466	CcSEcCtD
Zidovudine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000759	0.00464	CcSEcCtD
Zidovudine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000749	0.00457	CcSEcCtD
Zidovudine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000743	0.00454	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000741	0.00453	CcSEcCtD
Zidovudine—Rash—Spironolactone—dilated cardiomyopathy	0.000737	0.0045	CcSEcCtD
Zidovudine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000736	0.0045	CcSEcCtD
Zidovudine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000733	0.00448	CcSEcCtD
Zidovudine—Headache—Spironolactone—dilated cardiomyopathy	0.000732	0.00447	CcSEcCtD
Zidovudine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000729	0.00445	CcSEcCtD
Zidovudine—Anaemia—Furosemide—dilated cardiomyopathy	0.00072	0.0044	CcSEcCtD
Zidovudine—Sweating—Lisinopril—dilated cardiomyopathy	0.000717	0.00438	CcSEcCtD
Zidovudine—Haematuria—Lisinopril—dilated cardiomyopathy	0.000713	0.00436	CcSEcCtD
Zidovudine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000707	0.00432	CcSEcCtD
Zidovudine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000705	0.00431	CcSEcCtD
Zidovudine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000702	0.00429	CcSEcCtD
Zidovudine—Vertigo—Furosemide—dilated cardiomyopathy	0.0007	0.00427	CcSEcCtD
Zidovudine—ABCG2—heart—dilated cardiomyopathy	0.0007	0.0184	CbGeAlD
Zidovudine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000698	0.00426	CcSEcCtD
Zidovudine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000697	0.00426	CcSEcCtD
Zidovudine—Nausea—Spironolactone—dilated cardiomyopathy	0.000694	0.00424	CcSEcCtD
Zidovudine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000673	0.00411	CcSEcCtD
Zidovudine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000671	0.0041	CcSEcCtD
Zidovudine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000666	0.00407	CcSEcCtD
Zidovudine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000663	0.00405	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000658	0.00402	CcSEcCtD
Zidovudine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000658	0.00402	CcSEcCtD
Zidovudine—Confusional state—Furosemide—dilated cardiomyopathy	0.000641	0.00392	CcSEcCtD
Zidovudine—CYP2C9—heart—dilated cardiomyopathy	0.000639	0.0168	CbGeAlD
Zidovudine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000636	0.00388	CcSEcCtD
Zidovudine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000635	0.00388	CcSEcCtD
Zidovudine—Shock—Furosemide—dilated cardiomyopathy	0.000625	0.00382	CcSEcCtD
Zidovudine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000623	0.00381	CcSEcCtD
Zidovudine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000622	0.0038	CcSEcCtD
Zidovudine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000617	0.00377	CcSEcCtD
Zidovudine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000614	0.00375	CcSEcCtD
Zidovudine—Anorexia—Furosemide—dilated cardiomyopathy	0.000606	0.0037	CcSEcCtD
Zidovudine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000605	0.0037	CcSEcCtD
Zidovudine—Chills—Lisinopril—dilated cardiomyopathy	0.000602	0.00368	CcSEcCtD
Zidovudine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000588	0.00359	CcSEcCtD
Zidovudine—Erythema—Lisinopril—dilated cardiomyopathy	0.000584	0.00357	CcSEcCtD
Zidovudine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000584	0.00357	CcSEcCtD
Zidovudine—Flatulence—Lisinopril—dilated cardiomyopathy	0.000576	0.00352	CcSEcCtD
Zidovudine—Tension—Lisinopril—dilated cardiomyopathy	0.000573	0.0035	CcSEcCtD
Zidovudine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000572	0.0035	CcSEcCtD
Zidovudine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000571	0.00349	CcSEcCtD
Zidovudine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000568	0.00347	CcSEcCtD
Zidovudine—Back pain—Lisinopril—dilated cardiomyopathy	0.000565	0.00345	CcSEcCtD
Zidovudine—Somnolence—Furosemide—dilated cardiomyopathy	0.000565	0.00345	CcSEcCtD
Zidovudine—TERT—TGF-beta Signaling Pathway—RAC1—dilated cardiomyopathy	0.000562	0.00694	CbGpPWpGaD
Zidovudine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000562	0.00343	CcSEcCtD
Zidovudine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000553	0.00338	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000549	0.00335	CcSEcCtD
Zidovudine—Fatigue—Furosemide—dilated cardiomyopathy	0.000548	0.00335	CcSEcCtD
Zidovudine—Tremor—Lisinopril—dilated cardiomyopathy	0.000547	0.00334	CcSEcCtD
Zidovudine—Pain—Furosemide—dilated cardiomyopathy	0.000544	0.00332	CcSEcCtD
Zidovudine—Constipation—Furosemide—dilated cardiomyopathy	0.000544	0.00332	CcSEcCtD
Zidovudine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000542	0.00331	CcSEcCtD
Zidovudine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00054	0.0033	CcSEcCtD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000535	0.0066	CbGpPWpGaD
Zidovudine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000534	0.00326	CcSEcCtD
Zidovudine—Malaise—Lisinopril—dilated cardiomyopathy	0.000527	0.00322	CcSEcCtD
Zidovudine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000525	0.00321	CcSEcCtD
Zidovudine—Syncope—Lisinopril—dilated cardiomyopathy	0.000524	0.0032	CcSEcCtD
Zidovudine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000524	0.0032	CcSEcCtD
Zidovudine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000523	0.0032	CcSEcCtD
Zidovudine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000521	0.00643	CbGpPWpGaD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00052	0.00642	CbGpPWpGaD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00052	0.00642	CbGpPWpGaD
Zidovudine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00052	0.00318	CcSEcCtD
Zidovudine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000514	0.00314	CcSEcCtD
Zidovudine—Cough—Lisinopril—dilated cardiomyopathy	0.00051	0.00312	CcSEcCtD
Zidovudine—Urticaria—Furosemide—dilated cardiomyopathy	0.000505	0.00308	CcSEcCtD
Zidovudine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000502	0.00307	CcSEcCtD
Zidovudine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000502	0.00307	CcSEcCtD
Zidovudine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000498	0.00304	CcSEcCtD
Zidovudine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000498	0.00304	CcSEcCtD
Zidovudine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000498	0.00304	CcSEcCtD
Zidovudine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000496	0.00303	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000494	0.00302	CcSEcCtD
Zidovudine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000492	0.003	CcSEcCtD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000484	0.00597	CbGpPWpGaD
Zidovudine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000481	0.00294	CcSEcCtD
Zidovudine—Oedema—Lisinopril—dilated cardiomyopathy	0.000477	0.00291	CcSEcCtD
Zidovudine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000477	0.00291	CcSEcCtD
Zidovudine—Shock—Lisinopril—dilated cardiomyopathy	0.000469	0.00287	CcSEcCtD
Zidovudine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000467	0.00285	CcSEcCtD
Zidovudine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000463	0.00283	CcSEcCtD
Zidovudine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000461	0.00282	CcSEcCtD
Zidovudine—Asthenia—Furosemide—dilated cardiomyopathy	0.000456	0.00279	CcSEcCtD
Zidovudine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000455	0.00278	CcSEcCtD
Zidovudine—Pruritus—Furosemide—dilated cardiomyopathy	0.00045	0.00275	CcSEcCtD
Zidovudine—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000446	0.0055	CbGpPWpGaD
Zidovudine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000435	0.00266	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000435	0.00265	CcSEcCtD
Zidovudine—TERT—Regulation of Telomerase—EGFR—dilated cardiomyopathy	0.000434	0.00536	CbGpPWpGaD
Zidovudine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000431	0.00264	CcSEcCtD
Zidovudine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000428	0.00262	CcSEcCtD
Zidovudine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000425	0.0026	CcSEcCtD
Zidovudine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000424	0.00259	CcSEcCtD
Zidovudine—ABCC4—Ectoderm Differentiation—DMD—dilated cardiomyopathy	0.000422	0.0052	CbGpPWpGaD
Zidovudine—Dizziness—Furosemide—dilated cardiomyopathy	0.00042	0.00257	CcSEcCtD
Zidovudine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00042	0.00256	CcSEcCtD
Zidovudine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000415	0.00253	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000412	0.00252	CcSEcCtD
Zidovudine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000411	0.00251	CcSEcCtD
Zidovudine—Constipation—Lisinopril—dilated cardiomyopathy	0.000408	0.00249	CcSEcCtD
Zidovudine—Pain—Lisinopril—dilated cardiomyopathy	0.000408	0.00249	CcSEcCtD
Zidovudine—TK1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000406	0.00501	CbGpPWpGaD
Zidovudine—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000405	0.00499	CbGpPWpGaD
Zidovudine—Vomiting—Furosemide—dilated cardiomyopathy	0.000404	0.00247	CcSEcCtD
Zidovudine—Rash—Furosemide—dilated cardiomyopathy	0.000401	0.00245	CcSEcCtD
Zidovudine—Dermatitis—Furosemide—dilated cardiomyopathy	0.0004	0.00245	CcSEcCtD
Zidovudine—Headache—Furosemide—dilated cardiomyopathy	0.000398	0.00243	CcSEcCtD
Zidovudine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000393	0.0024	CcSEcCtD
Zidovudine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00039	0.00238	CcSEcCtD
Zidovudine—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000389	0.0048	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—TMPO—dilated cardiomyopathy	0.000385	0.00475	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000382	0.00471	CbGpPWpGaD
Zidovudine—TK1—Metabolism—TAZ—dilated cardiomyopathy	0.000381	0.00471	CbGpPWpGaD
Zidovudine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000379	0.00231	CcSEcCtD
Zidovudine—Nausea—Furosemide—dilated cardiomyopathy	0.000378	0.00231	CcSEcCtD
Zidovudine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000377	0.0023	CcSEcCtD
Zidovudine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000377	0.0023	CcSEcCtD
Zidovudine—TERT—TGF-beta Signaling Pathway—RAF1—dilated cardiomyopathy	0.000373	0.0046	CbGpPWpGaD
Zidovudine—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000372	0.00459	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000371	0.00458	CbGpPWpGaD
Zidovudine—ABCB1—heart—dilated cardiomyopathy	0.000345	0.00906	CbGeAlD
Zidovudine—TK1—Metabolism—SDHA—dilated cardiomyopathy	0.000345	0.00426	CbGpPWpGaD
Zidovudine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000342	0.00209	CcSEcCtD
Zidovudine—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00034	0.0042	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000338	0.00417	CbGpPWpGaD
Zidovudine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000337	0.00206	CcSEcCtD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000331	0.00408	CbGpPWpGaD
Zidovudine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000326	0.00199	CcSEcCtD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000322	0.00397	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—LMNA—dilated cardiomyopathy	0.000316	0.0039	CbGpPWpGaD
Zidovudine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000315	0.00193	CcSEcCtD
Zidovudine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000303	0.00185	CcSEcCtD
Zidovudine—Rash—Lisinopril—dilated cardiomyopathy	0.000301	0.00184	CcSEcCtD
Zidovudine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0003	0.00184	CcSEcCtD
Zidovudine—Headache—Lisinopril—dilated cardiomyopathy	0.000299	0.00183	CcSEcCtD
Zidovudine—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000287	0.00354	CbGpPWpGaD
Zidovudine—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000284	0.0035	CbGpPWpGaD
Zidovudine—Nausea—Lisinopril—dilated cardiomyopathy	0.000283	0.00173	CcSEcCtD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000281	0.00347	CbGpPWpGaD
Zidovudine—TERT—Signaling by Wnt—RAC1—dilated cardiomyopathy	0.000279	0.00344	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000273	0.00337	CbGpPWpGaD
Zidovudine—ABCC4—Platelet degranulation—CD36—dilated cardiomyopathy	0.000272	0.00335	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00026	0.00321	CbGpPWpGaD
Zidovudine—ABCC4—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000259	0.00319	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000246	0.00303	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000239	0.00295	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000239	0.00295	CbGpPWpGaD
Zidovudine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000237	0.00292	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000233	0.00287	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000227	0.0028	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000227	0.0028	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000222	0.00274	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000211	0.00261	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000211	0.0026	CbGpPWpGaD
Zidovudine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.00021	0.00259	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000208	0.00257	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000206	0.00254	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000206	0.00254	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000199	0.00246	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TTN—dilated cardiomyopathy	0.000197	0.00243	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000191	0.00236	CbGpPWpGaD
Zidovudine—TERT—Disease—NPPA—dilated cardiomyopathy	0.000191	0.00235	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.00019	0.00234	CbGpPWpGaD
Zidovudine—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000185	0.00228	CbGpPWpGaD
Zidovudine—TERT—Disease—PSEN2—dilated cardiomyopathy	0.000185	0.00228	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000178	0.00219	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000173	0.00213	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000173	0.00213	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000173	0.00213	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—ACTN2—dilated cardiomyopathy	0.000171	0.0021	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00017	0.0021	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000166	0.00204	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000166	0.00204	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000165	0.00204	CbGpPWpGaD
Zidovudine—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000165	0.00204	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000161	0.00199	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000161	0.00198	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000154	0.0019	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000154	0.0019	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—TAZ—dilated cardiomyopathy	0.000152	0.00187	CbGpPWpGaD
Zidovudine—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00015	0.00186	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00015	0.00185	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000148	0.00183	CbGpPWpGaD
Zidovudine—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000148	0.00182	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000147	0.00182	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—VCL—dilated cardiomyopathy	0.000145	0.00179	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000144	0.00178	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000144	0.00178	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000139	0.00172	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—SDHA—dilated cardiomyopathy	0.000137	0.00169	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000134	0.00165	CbGpPWpGaD
Zidovudine—SLC28A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000129	0.0016	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000129	0.0016	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000127	0.00157	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000125	0.00154	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000124	0.00153	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000123	0.00152	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000123	0.00151	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000121	0.0015	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000121	0.0015	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00012	0.00149	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00012	0.00148	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00012	0.00148	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000119	0.00147	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000117	0.00145	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000117	0.00144	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000117	0.00144	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000115	0.00142	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000115	0.00142	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000114	0.00141	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000114	0.0014	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000114	0.0014	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000113	0.00139	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—TAZ—dilated cardiomyopathy	0.000112	0.00138	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000112	0.00138	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000108	0.00134	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000108	0.00133	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000107	0.00132	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000107	0.00132	CbGpPWpGaD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000106	0.0013	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000105	0.00129	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000103	0.00128	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000102	0.00126	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—SDHA—dilated cardiomyopathy	0.000101	0.00125	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.6e-05	0.00118	CbGpPWpGaD
Zidovudine—TK1—Metabolism—GPX1—dilated cardiomyopathy	9.37e-05	0.00116	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.31e-05	0.00115	CbGpPWpGaD
Zidovudine—TERT—Disease—RAC1—dilated cardiomyopathy	9.29e-05	0.00115	CbGpPWpGaD
Zidovudine—TK1—Metabolism—CD36—dilated cardiomyopathy	9.12e-05	0.00113	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TTN—dilated cardiomyopathy	8.9e-05	0.0011	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.83e-05	0.00109	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.75e-05	0.00108	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NPPA—dilated cardiomyopathy	8.39e-05	0.00104	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.38e-05	0.00103	CbGpPWpGaD
Zidovudine—TK1—Metabolism—AGT—dilated cardiomyopathy	8.22e-05	0.00101	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	8.21e-05	0.00101	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PSEN2—dilated cardiomyopathy	8.13e-05	0.001	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	8.12e-05	0.001	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	7.72e-05	0.000952	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	7.72e-05	0.000952	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.71e-05	0.000951	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	7.64e-05	0.000943	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	7.53e-05	0.000929	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.5e-05	0.000925	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.5e-05	0.000925	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	7.46e-05	0.00092	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	7.28e-05	0.000899	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.2e-05	0.000888	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	7.19e-05	0.000887	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	7.01e-05	0.000865	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	6.98e-05	0.000861	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.97e-05	0.00086	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	6.91e-05	0.000852	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.75e-05	0.000833	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.57e-05	0.000811	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.57e-05	0.000811	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VCL—dilated cardiomyopathy	6.56e-05	0.00081	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—RAC1—dilated cardiomyopathy	6.5e-05	0.000802	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	6.34e-05	0.000783	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AGT—dilated cardiomyopathy	6.21e-05	0.000767	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	6.21e-05	0.000766	CbGpPWpGaD
Zidovudine—TERT—Disease—RAF1—dilated cardiomyopathy	6.16e-05	0.00076	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.11e-05	0.000754	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	5.92e-05	0.00073	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	5.85e-05	0.000722	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	5.85e-05	0.000722	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	5.45e-05	0.000673	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.35e-05	0.00066	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.16e-05	0.000637	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	5.14e-05	0.000634	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	5.09e-05	0.000629	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	5.07e-05	0.000625	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	5.06e-05	0.000624	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.85e-05	0.000598	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	4.79e-05	0.000591	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TAZ—dilated cardiomyopathy	4.76e-05	0.000588	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.65e-05	0.000574	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.59e-05	0.000567	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	4.55e-05	0.000561	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	4.53e-05	0.00056	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	4.44e-05	0.000548	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	4.44e-05	0.000548	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	4.33e-05	0.000535	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—RAF1—dilated cardiomyopathy	4.31e-05	0.000532	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SDHA—dilated cardiomyopathy	4.31e-05	0.000532	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	4.27e-05	0.000528	CbGpPWpGaD
Zidovudine—TERT—Disease—EGFR—dilated cardiomyopathy	4.22e-05	0.000521	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	4.17e-05	0.000515	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.17e-05	0.000514	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	4.15e-05	0.000512	CbGpPWpGaD
Zidovudine—ABCC5—Disease—RAC1—dilated cardiomyopathy	4.09e-05	0.000504	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	3.9e-05	0.000481	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	3.88e-05	0.000479	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	3.87e-05	0.000477	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	3.77e-05	0.000466	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GPX1—dilated cardiomyopathy	3.73e-05	0.00046	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CD36—dilated cardiomyopathy	3.63e-05	0.000448	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	3.53e-05	0.000435	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.5e-05	0.000432	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	3.41e-05	0.00042	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.36e-05	0.000415	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.35e-05	0.000414	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	3.29e-05	0.000407	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AGT—dilated cardiomyopathy	3.27e-05	0.000404	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—EGFR—dilated cardiomyopathy	2.96e-05	0.000365	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.92e-05	0.000361	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—CD36—dilated cardiomyopathy	2.81e-05	0.000347	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	2.75e-05	0.000339	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.73e-05	0.000337	CbGpPWpGaD
Zidovudine—ABCC5—Disease—RAF1—dilated cardiomyopathy	2.71e-05	0.000334	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	2.68e-05	0.000331	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—RAC1—dilated cardiomyopathy	2.65e-05	0.000327	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.64e-05	0.000326	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.63e-05	0.000324	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.57e-05	0.000318	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.57e-05	0.000317	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.56e-05	0.000316	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.46e-05	0.000304	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.44e-05	0.000301	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	2.41e-05	0.000298	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.36e-05	0.000291	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.32e-05	0.000287	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.32e-05	0.000286	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.3e-05	0.000284	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.3e-05	0.000284	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.3e-05	0.000283	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.19e-05	0.00027	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.15e-05	0.000265	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.09e-05	0.000258	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.07e-05	0.000255	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.9e-05	0.000234	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.89e-05	0.000233	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	1.88e-05	0.000232	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EGFR—dilated cardiomyopathy	1.86e-05	0.000229	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.85e-05	0.000228	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	1.83e-05	0.000226	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.76e-05	0.000217	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	1.72e-05	0.000213	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	1.68e-05	0.000207	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AGT—dilated cardiomyopathy	1.66e-05	0.000205	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	1.65e-05	0.000203	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.52e-05	0.000188	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	1.51e-05	0.000186	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.33e-05	0.000164	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.18e-05	0.000145	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GPX1—dilated cardiomyopathy	1.17e-05	0.000144	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.15e-05	0.000141	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CD36—dilated cardiomyopathy	1.14e-05	0.000141	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.05e-05	0.00013	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.03e-05	0.000127	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AGT—dilated cardiomyopathy	1.03e-05	0.000127	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.03e-05	0.000127	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.02e-05	0.000126	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	9.98e-06	0.000123	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	9.58e-06	0.000118	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	9.33e-06	0.000115	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	9.21e-06	0.000114	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	8.99e-06	0.000111	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	8.4e-06	0.000104	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	6.32e-06	7.79e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	6.15e-06	7.59e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.54e-06	6.83e-05	CbGpPWpGaD
